e-Drug3D

1542

M PRASUGREL


INN
PRASUGREL

(is an active metabolite)

cas 204204-73-9
CLASS

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE CLASS

ROUTE (list)

-

ATC code

B01AC22

PK parameters

F 79 PERCENT
Tmax 0.5 HOUR
VD 56 LITER
Cl 139 LITER / HOUR
PPB 98 PERCENT
t1/2 7 HOUR

Target

TARGET P2Y12 ADP RECEPTOR

DrugCentral

P2Y purinoceptor 12 UNIPROT Q9H244 P2RY12

Download SDF file Acetic acid, 2-[1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-mercapto-3-piperidinylidene]-, (2Z)-

Formula:
C18H20FNO3S

Calculated chemical properties:

MW 348.41
NB_atoms 24
XLogP 1.53
PSA 51.647
NB_HD 0
NB_HA 4
fsp3 0.44
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1474

PRASUGREL


INN
PRASUGREL

(has an active metabolite)

cas 150322-43-3
CLASS

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE CLASS

ROUTE (list)

ORAL

ATC code

B01AC22

PK parameters

F 79 PERCENT

Solubility

PRACTICALLY INSOLUBLE AT PH 6 TO 7.5


Target

TARGET P2Y12 ADP RECEPTOR

DrugCentral

P2Y purinoceptor 12 UNIPROT Q9H244 P2RY12

Download SDF file [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate

Formula:
C20H20FNO3S

Calculated chemical properties:

MW 373.44
NB_atoms 26
XLogP 3.89
PSA 43.701
NB_HD 0
NB_HA 4
fsp3 0.40
Lipinski(0=no;1=yes) 1

FDA
NDA 022307 (label) INN (PRASUGREL HYDROCHLORIDE) EFFIENT (COSETTE) APPROVAL= AP YEAR= 2009 NEWMOLECULARENTITY
NDA 205888 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2017
NDA 205927 (label) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (MYLAN) APPROVAL= AP YEAR= 2017
NDA 205897 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (PANACEA) APPROVAL= AP YEAR= 2017
NDA 205790 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (CHARTWELL RX) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 205987 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2018
NDA 205913 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (AMNEAL PHARMS) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 206021 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (HEC PHARM) APPROVAL= AP YEAR= 2019
NDA 205926 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (SENORES PHARMS) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 205930 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (LUPIN) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 213315 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL HYDROCHLORIDE (UNICHEM) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1493

PRASUGREL


INN
PRASUGREL

(has an active metabolite)

cas 150322-43-3
CLASS

BLOOD
ANTITHROMBOTIC AGENTS
P2Y(12) RECEPTOR ANTAGONIST
THIENOPYRIDINE CLASS

ROUTE (list)

ORAL

ATC code

B01AC22

PK parameters

F 79 PERCENT

Solubility

PRACTICALLY INSOLUBLE AT PH 6 TO 7.5


Target

TARGET P2Y12 ADP RECEPTOR

DrugCentral

P2Y purinoceptor 12 UNIPROT Q9H244 P2RY12

Download SDF file [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate

Formula:
C20H20FNO3S

Calculated chemical properties:

MW 373.44
NB_atoms 26
XLogP 3.89
PSA 44.419
NB_HD 0
NB_HA 4
fsp3 0.40
Lipinski(0=no;1=yes) 1

FDA
NDA 022307 (label) INN (PRASUGREL HYDROCHLORIDE) EFFIENT (COSETTE) APPROVAL= AP YEAR= 2009 NEWMOLECULARENTITY
NDA 205888 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2017
NDA 205927 (label) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (MYLAN) APPROVAL= AP YEAR= 2017
NDA 205897 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (PANACEA) APPROVAL= AP YEAR= 2017
NDA 205790 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (CHARTWELL RX) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 205987 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2018
NDA 205913 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (AMNEAL PHARMS) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 206021 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (HEC PHARM) APPROVAL= AP YEAR= 2019
NDA 205926 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (SENORES PHARMS) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 205930 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL (LUPIN) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 213315 (pdf not found) INN (PRASUGREL HYDROCHLORIDE) PRASUGREL HYDROCHLORIDE (UNICHEM) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL